Canada's Research-Based Pharmaceutical Companies (Rx&D)

Canada's Research-Based Pharmaceutical Companies (Rx&D)

November 17, 2014 12:00 ET

Media Advisory: Rx&D to Host 100th Anniversary Conference on Healthcare Innovation

TORONTO, ONTARIO--(Marketwired - Nov. 17, 2014) - Canada's Research-Based Pharmaceutical Companies (Rx&D) will host its first-ever stakeholder conference as part of ongoing 100th anniversary activities. The conference - Making Canada Better: Shaping the Next Century of Healthcare in Canada - will feature panel sessions with leading healthcare and life sciences experts as well as keynote speeches by Dr. Joel Dudley and the Honourable Kelvin K. Ogilvie, Senator.

WHAT: Rx&D 100th Anniversary Conference
WHERE: Metro Toronto Convention Centre
255 Front Street West
Toronto, ON
WHEN: Wednesday, November 19
Opening Plenary and Special Presentation (8:30-9:45 am)
• Mark Lievonen, President of Sanofi Pasteur Limited: New opportunities for Canada through collaboration
Morning Panel Sessions (10:15-11:30 am)
• Ethics: A collaborative approach
• Canadian research and commercialization
• Generating real-world evidence to inform health policy: what's working and what's needed?
Luncheon Keynote (12:00-1:30 pm)
• Dr. Joel Dudley, Director of Biomedical Informatics, Icahn School of Medicine at Mount Sinai: The future of medical science
Afternoon Panel Sessions (2:00-3:15 pm)
• Whose choice is it anyway? Are the complexities of Canada's drug coverage compromising patient care?
• Embracing personal technology for better health
• Linking intellectual property to increased Canadian health innovation
Closing Keynote (3:45-4:45 pm)
• The Honourable Kelvin K. Ogilvie, Senator: Building on 100 years of life science success in Canada

About Rx&D

Canada's Research-Based Pharmaceutical Companies is the national association representing the voice of Canada's innovative pharmaceutical industry. We serve our membership by advocating for policies that enable the discovery, development and delivery of innovative medicines and vaccines to improve the lives of all Canadians. We support our memberships' commitment to being a valued partner in the Canadian healthcare system. We represent more than 50 companies investing over $1-billion in R&D annually, fuelling Canada's knowledge-based economy, while contributing over $3-billion overall to Canada's economy. Guided by our Code of Ethical Practices, we work with governments, private payers, healthcare professionals and stakeholders in a highly ethical manner.

Contact Information